×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARAY – accuray incorporated (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARAY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
04:09 pm
aray
Accuray (NASDAQ:ARAY) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Accuray (NASDAQ:ARAY) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/20
11:01 am
aray
Global Veterinary Stereotactic Radiosurgery System Market to Hit USD 7.46 Billion by 2032 – SNS Insider [Yahoo! Finance]
Low
Report
Global Veterinary Stereotactic Radiosurgery System Market to Hit USD 7.46 Billion by 2032 – SNS Insider [Yahoo! Finance]
12/15
05:24 pm
aray
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth [Yah
Low
Report
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth [Yah
12/15
05:00 pm
aray
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
Low
Report
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
12/13
08:50 am
aray
Accuray Incorporated (NASDAQ:ARAY) is largely controlled by institutional shareholders who own 59% of the company [Yahoo! Finance]
Medium
Report
Accuray Incorporated (NASDAQ:ARAY) is largely controlled by institutional shareholders who own 59% of the company [Yahoo! Finance]
11/26
02:00 pm
aray
Accuray (NASDAQ:ARAY) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Accuray (NASDAQ:ARAY) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/6
08:10 am
aray
Accuray (NASDAQ:ARAY) had its price target lowered by analysts at BTIG Research from $5.00 to $4.00. They now have a "buy" rating on the stock.
Medium
Report
Accuray (NASDAQ:ARAY) had its price target lowered by analysts at BTIG Research from $5.00 to $4.00. They now have a "buy" rating on the stock.
11/5
04:05 pm
aray
Accuray Reports Fiscal 2026 First Quarter Financial Results
High
Report
Accuray Reports Fiscal 2026 First Quarter Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/22
03:49 pm
aray
Form 144 ACCURAY INC Filed by: Kill Robert
Low
Report
Form 144 ACCURAY INC Filed by: Kill Robert
12/16
06:03 am
aray
Form 8-K ACCURAY INC For: Dec 12
Low
Report
Form 8-K ACCURAY INC For: Dec 12
12/2
05:30 pm
aray
Form 4 ACCURAY INC For: Nov 28 Filed by: Chalke Sandeep
Neutral
Report
Form 4 ACCURAY INC For: Nov 28 Filed by: Chalke Sandeep
12/2
05:30 pm
aray
Form 4 ACCURAY INC For: Nov 28 Filed by: Pervaiz Ali
Neutral
Report
Form 4 ACCURAY INC For: Nov 28 Filed by: Pervaiz Ali
12/2
05:25 pm
aray
Form 4 ACCURAY INC For: Nov 28 Filed by: WHITTERS JOSEPH E
Neutral
Report
Form 4 ACCURAY INC For: Nov 28 Filed by: WHITTERS JOSEPH E
12/2
05:25 pm
aray
Form 4 ACCURAY INC For: Nov 28 Filed by: La Neve Stephen R.
Neutral
Report
Form 4 ACCURAY INC For: Nov 28 Filed by: La Neve Stephen R.
12/2
05:25 pm
aray
Form 4 ACCURAY INC For: Nov 28 Filed by: Peralta Leonel
Neutral
Report
Form 4 ACCURAY INC For: Nov 28 Filed by: Peralta Leonel
12/2
05:25 pm
aray
Form 4 ACCURAY INC For: Nov 28 Filed by: HUSS BEVERLY A
Neutral
Report
Form 4 ACCURAY INC For: Nov 28 Filed by: HUSS BEVERLY A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/28
Q3/2020 3/31/2020 EPS 0.030 ZacksConsensus -0.030 ActVsEst 0.060 - Beat
15.4%
1/28 Q2/2020 12/31/2019 EPS 0.120 ZacksConsensus -0.070 ActVsEst 0.190 - Beat 13.4%
12/25 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 8.2%
11/4 Form 4 ACCURAY INC For: Oct 31 Filed by: Chew Jesse 7.6%
11/1 Form 4 ACCURAY INC For: Oct 31 Filed by: Winter Suzanne C 7.4%
9/6 Form 4 ACCURAY INC For: Sep 04 Filed by: WHITTERS JOSEPH E 6.0%
2/11 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.6%
1/16 Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020 5.2%
1/21 Accuray Incorporated (NASDAQ: ARAY) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $9.50 price target on the stock. 5.2%
7/19 Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019 4.7%
1/28 Q2/2020 12/31/2019 EPS 0.120 ZacksConsensus -0.070 ActVsEst 0.190 - Beat 13.4%
12/25 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 8.2%
11/4 Form 4 ACCURAY INC For: Oct 31 Filed by: Chew Jesse 7.6%
11/1 Form 4 ACCURAY INC For: Oct 31 Filed by: Winter Suzanne C 7.4%
9/6 Form 4 ACCURAY INC For: Sep 04 Filed by: WHITTERS JOSEPH E 6.0%
2/11 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.6%
1/16 Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020 5.2%
1/21 Accuray Incorporated (NASDAQ: ARAY) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $9.50 price target on the stock. 5.2%
7/19 Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019 4.7%
TOP News Decliners
1/30
Accuray Incorporated (NASDAQ: ARAY) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating.
-11.0%
3/10 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -8.5%
8/15 Q4/2019 6/30/2019 EPS -0.020 ZacksConsensus 0.030 ActVsEst (0.050) - Miss -7.5%
8/2 Form 8-K ACCURAY INC For: Jul 30 -6.7%
4/28 Accuray Inc (ARAY) Q3 2020 Earnings Call Transcript [The Motley Fool] -5.9%
10/30 Accuray Drifting, And Critical Mass Seems Far Away [Seeking Alpha] -5.5%
9/17 Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated on a Conventional Linear Accelerator -5.2%
10/29 Q1/2020 9/30/2019 EPS -0.110 ZacksConsensus -0.100 ActVsEst (0.010) - Miss -4.8%
8/22 Form 8-K ACCURAY INC For: Aug 16 -4.7%
2/5 Studies Support Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects -4.3%
3/10 Accuray Incorporated (NASDAQ: ARAY) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -8.5%
8/15 Q4/2019 6/30/2019 EPS -0.020 ZacksConsensus 0.030 ActVsEst (0.050) - Miss -7.5%
8/2 Form 8-K ACCURAY INC For: Jul 30 -6.7%
4/28 Accuray Inc (ARAY) Q3 2020 Earnings Call Transcript [The Motley Fool] -5.9%
10/30 Accuray Drifting, And Critical Mass Seems Far Away [Seeking Alpha] -5.5%
9/17 Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated on a Conventional Linear Accelerator -5.2%
10/29 Q1/2020 9/30/2019 EPS -0.110 ZacksConsensus -0.100 ActVsEst (0.010) - Miss -4.8%
8/22 Form 8-K ACCURAY INC For: Aug 16 -4.7%
2/5 Studies Support Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects -4.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: